StreetInsider.com News Articles

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260615/26648393.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260615/26648393.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260615/26648393.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260615/26648393.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260615/26644074.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260615/26644074.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260615/26644074.html

Form 424B3 Semnur Pharmaceuticals,

Mon, 15 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260615/26644074.html

Form SEC STAFF ACTION Sorrento Therapeutics,

Fri, 21 Feb 2025 17:00:00 -0400

si-local-file:///var/storage/secattach/20250221/24386906.html

Form SEC STAFF ACTION Sorrento Therapeutics,

Fri, 21 Feb 2025 17:00:00 -0400

si-local-file:///var/storage/secattach/20250221/24386906.html

Scilex Holding (SCLX) Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to

Fri, 31 Jan 2025 09:01:17 -0400

Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, in neurodegenerative and cardiometabolic disease, today announced that the U.S. Bankruptcy Court for the Southern District of Texas (the “Court”) has extended the expiration of the restrictions on transfer of the shares of common stock of Scilex that were previously distributed by Sorrento Therapeutics, Inc. (OTC: SRNE, “Sorrento”), Scilex’s former controlling stockholder, to Sorrento’s stockholders as a dividend

Scilex Holding (SCLX) Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to

Fri, 31 Jan 2025 09:01:17 -0400

Scilex Holding (SCLX) Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to

Fri, 31 Jan 2025 09:01:17 -0400

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend t

Fri, 31 Jan 2025 09:00:00 -0400

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.
Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.
Scilex’s transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to April 14, 2025.